Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

National Drug Code

Is NDC 64764-0080-60 recalled?

Amitiza

Yes — this exact package was recalled

2 FDA recalls name the code 64764-0080-60 directly. A recall still applies to particular lot numbers — compare the lot on your package with the FDA notice below, and talk to your pharmacist before stopping a prescribed medication.

Active ingredient
lubiprostone
Strength
LUBIPROSTONE 8 ug/1
Form
Capsule, Gelatin Coated · Oral
Labeler
Takeda Pharmaceuticals America, Inc.
Type
Human Prescription Drug
Product code
64764-0080

Recalls naming this package

Class II · Moderate risk

Amitiza (lubiprostone)

Labeling: Label mix-up. Amitiza 8 mcg capsules are being recalled because 24 mcg capsules were found in a 8 mcg trade 60 ct. bottle. Amitiza 24 mcg capsules are being recalled because a sealed 60 ct. bottle contained only 8 mcg capsules, this incident is being considered as a labeling mix-up issue.

Terminated Labeling / mix-up Mallinckrodt Pharmaceuticals NDC 64764-080-60 D-1294-2019
Class III · Low risk

AMITIZA (lubiprostone)

Failed Impurities/Degradation Specifications:Elevated levels of a known impurity in the 20-month stability sample testing.

Terminated Impurity / degradation Takeda Development Center Americas, Inc. NDC 64764-080-60 D-0286-2019

Where to find this code. The NDC is printed on the pharmacy label and on the manufacturer's carton, usually as three groups of digits after “NDC”. The last group is the package size — two bottles of the same medicine can differ only in that group, and a recall may cover one but not the other.

Other recalled products from this labeler